Esther Dillard: Access to Gene Therapy for Sickle Cell Disease
Esther Dillard, Anchor and Reporter for the Black Information Network at iHeartMedia, shared a post on LinkedIn:
“Gene therapy for sickle cell disease is one of the safest cures medicine has ever produced. A one-time treatment. Not a lifetime of transfusions and pain crises. A cure.
But access isn’t equal.
In this week’s episode of The Color Between the Lines, Dr. Haydar Frangoul explains why families in places like Alabama often have to travel hundreds of miles and wait months just to reach a center that can perform this treatment. That’s not an accident. That’s a choice, about where hospitals invest, who gets access to specialists, and which communities get left out of medical breakthroughs.
Full conversation this week.”
Stay updated with Hemostasis Today.
-
Aug 27, 2026, 15:59Leslie Iverson: What Does a Zero CAC Score Really Mean?
-
Aug 27, 2026, 15:42Shahram Raza Shouq: Small Steps Toward a Thalassaemia-Free Future
-
Aug 27, 2026, 15:27Dai H. Chung: A New Foundation for Studying Pediatric Pulmonary Embolism
-
Aug 27, 2026, 15:10David McIntosh: The World Needs More Blood Collectors, Not Just More Donors
-
Aug 27, 2026, 14:46Maria Espanol: Comprehensive Review on Pediatric Venous Thromboembolism Now Available in RPTH
-
Aug 27, 2026, 14:40Santagata Davide: Thrombin Generation and Comparative Anticoagulant Pharmacodynamics
-
Aug 27, 2026, 14:33Shaleen Dass: Early Prediction of Blood Transfusion Requirements in Trauma Patients
-
Aug 27, 2026, 14:26Davide Capodanno: The Trade-Offs of Left Atrial Appendage Closure
-
Aug 27, 2026, 14:18A Simple Intervention to Reduce Maternal Anemia – UT Southwestern Medical Center